Palisade Bio (PALI) Other Non-Current Liabilities (2012 - 2026)
Palisade Bio (PALI) posted Other Non-Current Liabilities of $259,000 for Q2 2026, up 245.3% from $75,000 a year earlier but down 4.4% from the prior quarter.
Palisade Bio (PALI) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Palisade Bio's Other Non-Current Liabilities came in at $266,000, up 77.3% from FY2024.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of -32.0% (FY2020 to FY2025).
- In prior years, Palisade Bio's Other Non-Current Liabilities was $150,000 in FY2024 (+145.9%), $61,000 in FY2023 (unchanged), $61,000 in FY2022 (-97.7%) and $2.65 million in FY2021 (+44.9%).
- Quarterly Other Non-Current Liabilities has run from a low of $2,000 in Q2 2023 to a high of $9.43 million in Q3 2021 over five years.
- On a year-over-year basis, Other Non-Current Liabilities has increased in each of the last seven quarters, with growth averaging 151.7% over the last eight quarters.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q1 2022, with growth of 889.5%; the weakest was Q2 2023, with a decline of 99.6%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $271,000 (Q1 2026), $266,000 (Q4 2025) and $283,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Palisade Bio | 234.35 Mn | -162.09 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 259,000.00 |
| Mar 31, 2026 | 271,000.00 |
| Dec 31, 2025 | 266,000.00 |
| Sep 30, 2025 | 283,000.00 |
| Jun 30, 2025 | 75,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 212,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 61,000.00 |
| Sep 30, 2022 | 84,000.00 |
| Jun 30, 2022 | 469,000.00 |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 2.65 Mn |
| Sep 30, 2021 | 9.43 Mn |
Palisade Bio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PALI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();